MetaviaMTVA
13F holders, Q3 2024 (September 30)13holders +1
2new positions
1sold out
$3.17avg. 13F price*
At the end of Q3 2024, 13 institutions reported holding Metavia Inc. (MTVA) in their 13F filings, up 1 from Q2 2024. 2 opened new positions and 1 sold out. The largest holders were Armistice Capital, LLC ($2.7M), Affinity Asset Advisors, LLC ($283K) and Vanguard Group Inc. ($192K).
- Company
- Metavia Inc.
- Filed as
- NEUROBO PHARMACEUTICALS INC (Q3 2024)
- CUSIP
- 64132R404
- Latest filing quarter
- Q3 2025
History
Number of 13F holders
Total Exit/New Position Q2 2024 → Q3 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 2 | $91K |
| Exits | 1 | $121 |
All 13F filers, Q2 2024 → Q3 2024: 202,824 shares bought and 155 shares sold, net +202,669 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 13 holders
| Armistice Capital, LLC | 0.07% | Add +21.7% | 848,000 | $2.7M |
| Affinity Asset Advisors, LLC | 0.05% | No change | 89,222 | $283K |
| Vanguard Group Inc. | 0.00% | Add +27.7% | 60,452 | $192K |
| Geode Capital Management, LLC | 0.00% | Add +41.2% | 32,574 | $103K |
| Ferguson Wellman Capital Management, Inc. | 0.00% | New | 15,670 | $50K |
| State Street Corp. | 0.00% | No change | 15,633 | $50K |
| Northern Trust Corp. | 0.00% | No change | 13,508 | $43K |
| UBS Group AG | 0.00% | New | 12,952 | $41K |
| BlackRock, Inc. | 0.00% | — | 5,274 | $17K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +40.7% | 1,431 | $5K |
| Bank of America Corp. | 0.00% | Reduce -81.3% | 30 | $95 |
| JPMorgan Chase & Co. | 0.00% | Add +40.0% | 7 | $22 |
| BNP Paribas Financial Markets | 0.00% | No change | 4 | $13 |
"% of holder's portfolio" is MTVA's weight in each manager's 13F, not the share of Metavia Inc. the manager owns.